It is known that in general, in leukemia, the MDR1 phenotype is generally acquired after the administration of chemotherapeutic agents and is more frequent in ALL and in aggressive carcinomas (e.g., breast and ovarian) [21]. This evidence concerns the gene ABCB1 and leukemia.